Walgreens Boots Alliance, Inc. WBA
Set alert
At close · Aug 28
- YTD
- +28.40%
- 1 year
- +26.77%
- Open
- 11.98
- Prev close
- 11.98
- Mkt cap
- 10.37B
- Vol
- 452.08M
- Avg vol
- 16.12M
- EPS
- -7.29
- P/E
- 7.09
- Div yield
- 8.35%
More statistics
- Low
- 11.98
- High
- 11.98
- Forward P/E
- 8.15
- Beta
- 0.77
- Short ratio
- 3.35
- Inst. own
- 60.94%
- Dividend
- 1.00
- Ex-div date
- Nov 17, 2024
- Earnings
- Oct 21, 2025
- 50-d avg
- 11.68
- 200-d avg
- 10.90
- 1y target
- 12.11
MAX chart
Events in this range
- Nov 12, 2021Dividend: 0.477
- Nov 13, 2021Dividend: 0.477
- Feb 17, 2022Dividend: 0.4775
- May 19, 2022Dividend: 0.477
- Aug 18, 2022Dividend: 0.48
- Nov 14, 2022Dividend: 0.48
- Dec 12, 2022Dividend: 0.48
- Feb 15, 2023Dividend: 0.48
- May 18, 2023Dividend: 0.48
- Aug 18, 2023Dividend: 0.48
- Nov 13, 2023Dividend: 0.48
- Feb 16, 2024Dividend: 0.25
- Feb 20, 2024Dividend: 0.25
- May 20, 2024Dividend: 0.25
- Jun 27, 2024Earnings: —; estimate 0.67; surprise —%
- Aug 21, 2024Dividend: 0.25
- Oct 15, 2024Earnings: —; estimate 0.36; surprise —%
- Nov 18, 2024Dividend: 0.25
- Jan 10, 2025Earnings: —; estimate 0.37; surprise —%
- Jan 13, 2025Rating: B of A Securities · Underperform → Underperform
- Jan 13, 2025Rating: Evercore ISI Group · In-Line → In-Line
- Jan 16, 2025Rating: Truist Securities · Hold → Hold
- Jan 31, 2025Rating: Truist Securities · Hold → Hold
- Feb 28, 2025Downgrade: Deutsche Bank · Hold → Sell
- Apr 8, 2025Earnings: —; estimate 0.53; surprise —%
- Jun 26, 2025Earnings: —; estimate 0.34; surprise —%
Signals (50)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | May 9, 2025 | 1 year ago |
| SMA: Bearish | May 2, 2025 | 1 year ago |
| SMA: Bullish | Apr 17, 2025 | 1 year ago |
| SMA: Bearish | Apr 10, 2025 | 1 year ago |
| SMA: Bullish | Mar 13, 2025 | 1 year ago |
| SMA: Bearish | Mar 6, 2025 | 1 year ago |
| SMA: Bullish | Feb 20, 2025 | 1 year ago |
| SMA: Bullish | Feb 20, 2025 | 1 year ago |
| SMA: Bearish | Feb 13, 2025 | 1 year ago |
| SMA: Bearish | Feb 6, 2025 | 1 year ago |
| SMA: Bullish | Jan 16, 2025 | 1 year ago |
| SMA: Bullish | Jan 16, 2025 | 1 year ago |
| SMA: Bearish | Jan 8, 2025 | 1 year ago |
| SMA: Bullish | Dec 31, 2024 | 1 year ago |
| SMA: Bearish | Dec 24, 2024 | 1 year ago |
| SMA: Bullish | Dec 10, 2024 | 1 year ago |
| SMA: Bearish | Nov 12, 2024 | 1 year ago |
| SMA: Bullish | Oct 21, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 30, 2024 | 2 years ago |
| RSI: Oversold | Jul 1, 2024 | 2 years ago |
| RSI: Oversold | Jun 17, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 5, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 28, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 14, 2024 | 2 years ago |
| SMA: Bearish | Jan 18, 2024 | 2 years ago |
| SMA: Bearish | Jan 4, 2024 | 2 years ago |
| SMA: Bullish | Dec 21, 2023 | 2 years ago |
| SMA: Bullish | Dec 7, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 22, 2023 | 2 years ago |
| RSI: Oversold | Nov 22, 2023 | 2 years ago |
| RSI: Oversold | Oct 24, 2023 | 3 years ago |
| RSI: Oversold | Aug 29, 2023 | 3 years ago |
| SMA: Bearish | Aug 1, 2023 | 3 years ago |
| SMA: Bullish | Jul 25, 2023 | 3 years ago |
| RSI: Oversold | May 30, 2023 | 3 years ago |
| MACD: Sell Signal | May 2, 2023 | 3 years ago |
| SMA: Bearish | Apr 25, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 11, 2023 | 3 years ago |
| SMA: Bullish | Apr 4, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 21, 2023 | 3 years ago |
| SMA: Bearish | Jan 3, 2023 | 3 years ago |
| SMA: Bearish | Dec 27, 2022 | 3 years ago |
| SMA: Bullish | Nov 15, 2022 | 3 years ago |
| MACD: Buy Signal | Oct 31, 2022 | 4 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| MACD: Sell Signal | Aug 29, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| SMA: Bullish | Aug 15, 2022 | 4 years ago |
| MACD: Buy Signal | Aug 8, 2022 | 4 years ago |
| SMA: Bearish | Jan 31, 2022 | 4 years ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 39.67B
- Trailing P/E
- 0.00
- Forward P/E
- 8.15
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 1.44
- EPS (TTM)
- -7.29
- Beta
- 0.77
- Dividend yield
- 8.35%
- Payout ratio
- 290.91%
- Profit margin
- -4.07%
- Revenue (TTM)
- 154.58B
- Revenue growth
- 7.20%
- Free cash flow
- 4.52B
- Total cash
- 830.00M
- Total debt
- 30.00B
- Return on equity
- -69.58%
- Shares outstanding
- 865.56M
- Short % of float
- 3.58%
- 50-day average
- 11.68
- 200-day average
- 10.90
Analyst view
Consensus: hold
- Target (low)
- 11.00
- Target (mean)
- 12.11
- Target (high)
- 15.00
- Strong buy0
- Buy1
- Hold7
- Sell0
- Strong sell0
Next earnings
Oct 21, 2025
Expected Oct 21, 2025. Consensus EPS estimate 0.25901.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 21, 2025 | Aug 1, 2025 | 0.27 | — | — | — |
| Jun 26, 2025 | May 1, 2025 | 0.34 | — | — | — |
| Apr 8, 2025 | Feb 1, 2025 | 0.53 | — | — | — |
| Jan 10, 2025 | Nov 1, 2024 | 0.37 | — | — | — |
| Oct 15, 2024 | Aug 1, 2024 | 0.36 | — | — | — |
| Jun 27, 2024 | May 1, 2024 | 0.67 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 28, 2025 | Deutsche Bank | down | Hold | Sell |
| Jan 31, 2025 | Truist Securities | main | Hold | Hold |
| Jan 16, 2025 | Truist Securities | main | Hold | Hold |
| Jan 15, 2025 | RBC Capital | main | Sector Perform | Sector Perform |
| Jan 13, 2025 | Evercore ISI Group | main | In-Line | In-Line |
| Jan 13, 2025 | B of A Securities | main | Underperform | Underperform |
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Country
- United States
- Website
- walgreensbootsalliance.com
News
- A Sinking Ship or A Turnaround Bet
- US pharmacy chain Walgreens plans tech centre in India's Chennai, expected to create 250 jobs
- Walgreens Pharmacists Help Medicare Patients Navigate New Access to GLP‑1 Medications
- Walgreens Boosts Pharmacy Access with Expanded Hours on 4th of July
- Walgreens Helps FIFA World Cup™ Fans in Miami Stay Game-Ready with Pharmacy Care and Everyday Essentials
- Walgreens Helps FIFA World Cup™ Fans in Dallas Stay Game-Ready with Pharmacy Care and Everyday Essentials
- Walgreens Helps FIFA World Cup™ Fans in Houston Stay Game-Ready with Pharmacy Care and Everyday Essentials
- Walgreens Helps FIFA World Cup™ Fans in Atlanta Stay Game-Ready with Pharmacy Care and Everyday Essentials
- Walgreens Helps FIFA World Cup™ Fans in Seattle Stay Game-Ready with Pharmacy Care and Everyday Essentials
- Walgreens Helps FIFA World Cup™ Fans in New York Stay Game-Ready with Pharmacy Care and Everyday Essentials
Your note
Sign in to keep a note on WBA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| FABBRI BETH AMBER L. | Officer | Stock Award(Grant) | Oct 31, 2024 | 123,130 |
| GATES RICHARD P | Officer | Stock Award(Grant) | Oct 31, 2024 | 141,520 |
| HANSON BRYAN C | Director | Stock Award(Grant) | Aug 12, 2025 | 47,655 |
| HECKMAN TODD | Officer | Stock Award(Grant) | Oct 31, 2024 | 92,350 |
| LANGOWKSI MARY | Officer | Stock Award(Grant) | Oct 31, 2024 | 519,600 |
| MAHAJAN MANMOHAN LAL | Officer | Stock Award(Grant) | Oct 31, 2024 | 414,064 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 9.60% | 83,119,485 | 995.77M | Jun 29, 2025 |
| Blackrock Inc. | 5.93% | 51,366,742 | 615.37M | Jun 29, 2025 |
| State Street Corporation | 3.73% | 32,243,219 | 386.27M | Jun 29, 2025 |
| Invesco Ltd. | 2.67% | 23,141,239 | 277.23M | Jun 29, 2025 |
| FMR, LLC | 2.57% | 22,216,576 | 266.15M | Jun 29, 2025 |
| FIL LTD | 2.38% | 20,609,000 | 246.90M | Jun 29, 2025 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.58% | 22,292,701 | 267.07M | Jun 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.35% | 20,372,818 | 244.07M | Jun 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.96% | 16,931,841 | 202.84M | Jun 29, 2025 |
| Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF | 1.46% | 12,597,549 | 150.92M | Jun 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 1.25% | 10,813,864 | 129.55M | Jun 29, 2025 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.05% | 9,094,105 | 108.95M | Jun 29, 2025 |